The Harmony Prenatal Test relies on a proprietary targeted DNA-based technology (DANSR and FORTE) to provide exceptionally accurate results.
During pregnancy, the mother's blood contains fragments of the developing baby’s DNA. The Harmony test analyzes this DNA in a blood sample to assess the chance for Down syndrome (trisomy 21), as well as trisomies 18 and 13, in the pregnancy.
Targeted analysis results in higher throughput and accurate trisomy risk assessment. 1